Marine-derived n-3 fatty acids therapy for stroke

Celia Gabriela Alvarez Campano (Corresponding Author), Mary J. Macleod, Lorna S. Aucott, Frank Thies

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)



With stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.


To assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.

Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.
Original languageEnglish
Pages (from-to)e314-e315
Number of pages2
Issue number11
Early online date26 Sep 2019
Publication statusPublished - 1 Nov 2019


  • stroke
  • treatment
  • functional recovery
  • marine-derived n-3 PUFAs
  • death
  • n-3 fatty acids
  • quality of life
  • incidence
  • neuroprotective effect


Dive into the research topics of 'Marine-derived n-3 fatty acids therapy for stroke'. Together they form a unique fingerprint.

Cite this